Anglo-Swedish pharmaceutical company AstraZeneca has reported a 56 percent drop in net income in the third quarter as it suffered from the loss of exclusivity on a big-selling drug.
URL: http://www.topix.com/health/depression/2012/10/loss-of-exclusive-drug-dents-astrazenecas-q3?fromrss=1
No comments:
Post a Comment